Asset
Cetuximab
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04670679 | phase1 | active_not_recruiting | 2020-12-15 | 2026-02-01 | Erasca, Inc. | A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors |
| NCT05039177 | phase1_2 | completed | 2021-09-20 | 2025-08-15 | Erasca, Inc. | A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies |
FDA applications (0)
This company has no applications containing this asset.